破局基层用药痛点，海尔生物医疗以数智化方案引领县域药学服务新变革

Core Insights - The second County Health Key Specialty Construction Conference was held in Chengdu, focusing on practical experiences and future development paths for county-level specialty construction [1] - Haier Biomedical showcased its innovations in smart medication and received the "County Key Specialty Construction Ecological Partner Contribution Award" for its contributions to the digital transformation of grassroots pharmaceutical services [1][3] Industry Overview - China's county-level healthcare system is entering a phase of high-quality development, with a focus on enhancing the service capabilities of county hospitals as part of national medical reform [3] - Pharmaceutical services are critical for medical quality and safety, particularly at the grassroots level, facing challenges such as reliance on manual processes, inefficiencies, and difficulties in drug traceability [3] Company Innovations - Haier Biomedical launched a fully digital closed-loop solution for hospital drug "storage, transfer, and distribution," integrating IoT, automation, and AI to reconstruct traditional pharmaceutical service models [3] - This solution has been implemented in over 400 medical institutions nationwide, improving drug management efficiency and medication safety, providing a replicable and scalable path for county hospital pharmaceutical specialty construction [3] Strategic Developments - During the conference, Haier Biomedical's market director delivered a speech on the exploration and practice of precise pharmaceutical services in county areas, emphasizing the need for a comprehensive upgrade rather than just adding smart devices [4] - The company is expanding its product matrix and full-scene solutions, including smart intravenous preparation centers and smart outpatient pharmacies, while focusing on AI integration and new product development [6] International Expansion - Haier Biomedical's innovations are moving towards international markets, with a recent strategic partnership with RAM Medical Group in Thailand, marking its entry into the Southeast Asian healthcare market [6] - The company aims to drive the construction of a new digital ecosystem for pharmaceutical services globally, supporting the "Healthy China" strategy and the establishment of a global health community [6]